KLRS
Kalaris Therapeutics, Inc.
2.90$
-4.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | -1,137.3% | – | – | – | – | – | – | |
| – | – | +284.2% | +1,430.1% | – | – | – | – | |
| – | – | – | – | – | -45.4% | +504.7% | +116.3% | |
| – | -59.0% | -173.9% | – | -82.5% | -132.2% | – | – | |
| – | – | -30.7% | -88.9% | -100.0% | – | – | – | |
| – | – | +162.2% | – | – | – | – | -120.8% | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +39.5% | +232.8% | -62.4% | |
| – | +428.7% | +141.5% | -99.9% | +5,408.6% | +11.4% | -99.9% | +759,961.9% | |
| – | +44.7% | +70.5% | +28.3% | -96.2% | -96.3% | +25,507.3% | -171.8% | |
| – | -1,154.8% | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.